Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$120.0 - $182.95 $214,920 - $327,663
1,791 Added 14.46%
14,178 $1.79 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $731,792 - $893,079
4,285 Added 52.89%
12,387 $2.28 Million
Q4 2023

Feb 12, 2024

BUY
$114.17 - $185.35 $111,772 - $181,457
979 Added 13.74%
8,102 $1.46 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $262,294 - $333,603
-1,890 Reduced 20.97%
7,123 $1.13 Million
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $37,511 - $48,864
271 Added 3.1%
9,013 $1.27 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $967,364 - $1.24 Million
6,271 Added 253.78%
8,742 $1.47 Million
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $401,339 - $545,003
2,471 New
2,471 $418,000
Q2 2022

Aug 11, 2022

BUY
$140.68 - $188.02 $108,604 - $145,151
772 Added 38.91%
2,756 $448,000
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $121,376 - $194,243
753 Added 61.17%
1,984 $377,000
Q4 2021

Feb 11, 2022

BUY
$247.59 - $304.47 $304,783 - $374,802
1,231 New
1,231 $326,000
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $447,386 - $744,710
-2,297 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $209,327 - $278,838
-1,262 Reduced 35.46%
2,297 $458,000
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $764,588 - $959,116
-4,239 Reduced 54.36%
3,559 $691,000
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $482,740 - $673,418
3,260 Added 71.84%
7,798 $1.49 Million
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $94,087 - $121,551
768 Added 20.37%
4,538 $673,000
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $70,747 - $105,359
-750 Reduced 16.59%
3,770 $466,000
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $163,548 - $210,094
-1,925 Reduced 29.87%
4,520 $436,000
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $5,464 - $6,887
74 Added 1.16%
6,445 $601,000
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $93,359 - $116,331
1,218 Added 23.64%
6,371 $488,000
Q2 2019

Aug 13, 2019

BUY
$54.2 - $85.95 $33,549 - $53,203
619 Added 13.65%
5,153 $443,000
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $224,206 - $284,735
4,534 New
4,534 $267,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.